Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

Outbreaks of emerging infections present health professionals with the unique challenge of trying to select appropriate pharmacologic treatments in the clinic with little time available for drug testing and development. Typically, clinicians are left with general supportive care and often untested c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Dyall, Julie, Coleman, Christopher M., Hart, Brit J., Venkataraman, Thiagarajan, Holbrook, Michael R., Kindrachuk, Jason, Johnson, Reed F., Olinger, Gene G., Jahrling, Peter B., Laidlaw, Monique, Johansen, Lisa M., Lear-Rooney, Calli M., Glass, Pamela J., Hensley, Lisa E., Frieman, Matthew B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2014
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4136000/
https://ncbi.nlm.nih.gov/pubmed/24841273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03036-14
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi